"2013 was an outstanding year as we delivered strong top-line growth, generated significant cash flow and executed on our corporate development strategy," said , chairman and chief executive officer of Jazz Pharmaceuticals plc.
http://ift.tt/MZVtLG
http://ift.tt/MZVtLG
No comments:
Post a Comment